Antibiotice Ia (ATB) — Net Asset Quality Index
Antibiotice Ia (ATB) has a Net Asset Quality Index of 63.3% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of RON1.49 Billion minus total liabilities of RON548.43 Million yields net assets of RON944.64 Million. A higher index indicates a stronger, lower-leverage balance sheet. For live market cap and overall valuation, see Antibiotice Ia market cap and net worth.
Quality Index
Net Assets
Total Assets
Total Liabilities
Antibiotice Ia Net Asset Quality Index Over Time (2020–2025)
This chart shows how Antibiotice Ia's Net Asset Quality Index has evolved across 6 annual periods from 2020 to 2025. As of March 2026, the index stands at 63.3%, representing net assets of RON944.64 Million against total assets of RON1.49 Billion RON. See Antibiotice Ia shareholders equity for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Antibiotice Ia (2020–2025)
The table below presents the year-by-year Net Asset Quality Index for Antibiotice Ia from 2020 to 2025, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Also explore ATB year-over-year net asset growth to track the company's year-over-year net asset growth rate.
| Year | Quality Index | Net Assets (RON) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 66.9% | RON932.07 Million | RON1.39 Billion | RON460.49 Million | ▼ -3.0 pp |
| 2024 | 69.9% | RON894.31 Million | RON1.28 Billion | RON384.95 Million | ▼ -4.4 pp |
| 2023 | 74.3% | RON846.96 Million | RON1.14 Billion | RON292.21 Million | ▼ -0.5 pp |
| 2022 | 74.9% | RON641.43 Million | RON856.47 Million | RON215.04 Million | ▲ +7.3 pp |
| 2021 | 67.6% | RON604.99 Million | RON895.39 Million | RON290.40 Million | ▲ +0.7 pp |
| 2020 | 66.9% | RON577.27 Million | RON863.00 Million | RON285.73 Million | — |